A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects
Clinical trial NCT04859452 · COMPLETED
Trial details
- NCT number
- NCT04859452
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-26
- Primary completion
- 2021-07-03
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.